PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1618150
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1618150
Dialysis Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032
The Global Dialysis Market was valued at USD 92.1 billion in 2023 and is projected to grow at a CAGR of 5.5% from 2024 to 2032. This growth is driven by advancements in dialysis technologies, an increasing prevalence of chronic kidney disease (CKD), an aging population, and the rising adoption of home-based dialysis solutions. Innovative developments in dialysis equipment, such as portable machines, home dialysis systems, and more efficient dialysis solutions, improve patient outcomes and offer greater convenience. These innovations reduce treatment times and enhance flexibility, particularly with the growing trend toward home dialysis and wearable technologies. This shift not only improves patient quality of life but also helps reduce the strain on healthcare facilities.
The market is segmented into hemodialysis and peritoneal dialysis based on treatment type. In 2023, the hemodialysis segment accounted for USD 79.5 billion in revenue, making it the leading treatment modality. Hemodialysis is essential for managing advanced CKD and end-stage renal disease (ESRD), as it filters waste and excess fluids from the blood. Cardiovascular diseases, a leading cause of kidney damage, continue to contribute to the growing need for hemodialysis, with demand expected to rise as heart disease remains prevalent.
In terms of products and services, the market is categorized into services, consumables, and equipment. The services segment dominated in 2023, capturing 79% of the market share. The expansion of dialysis centers, especially in urban and semi-urban areas, has increased access to vital treatment. Major dialysis providers are investing in more facilities in regions with a high prevalence of CKD, supporting the growth of both in-hospital and outpatient services.
| Market Scope | |
|---|---|
| Start Year | 2023 |
| Forecast Year | 2024-2032 |
| Start Value | $92.1 Billion |
| Forecast Value | $148.1 Billion |
| CAGR | 5.5% |
This expansion is key to ensuring more patients receive consistent care. North America led the market with USD 31.8 billion in revenue in 2023 and is expected to grow at a 5.4% CAGR through 2032. The region benefits from continuous advancements in dialysis technologies and treatment options. New innovations, such as more efficient hemodialysis machines, portable peritoneal dialysis systems, and home dialysis devices, enhance patient comfort and improve clinical outcomes. These developments are increasing the adoption of advanced dialysis solutions, thus improving access to renal care services across North America.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope & definition
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
- 1.4 Forecast model
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Rising number of end stage renal diseases (ESRD) patients
- 3.2.1.2 Increasing incidence of diabetes
- 3.2.1.3 Shortage of donor kidneys
- 3.2.1.4 Favorable reimbursement scenario available for dialysis treatment
- 3.2.1.5 Growing R&D investments in developed as well as developing countries
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 Product recalls
- 3.2.2.2 Complications in the treatment
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.5 Reimbursement scenario
- 3.6 Technology landscape
- 3.7 Value chain analysis
- 3.8 Porter's analysis
- 3.9 PESTEL analysis
- 3.10 Gap analysis
- 3.11 Future market trends
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company matrix analysis
- 4.3 Competitive analysis of major market players
- 4.4 Competitive positioning matrix
- 4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)
- 5.1 Key trends
- 5.2 Hemodialysis
- 5.3 Peritoneal dialysis
Chapter 6 Market Estimates and Forecast, By Product and Services, 2021 - 2032 ($ Mn)
- 6.1 Key trends
- 6.2 Services
- 6.2.1 Chronic dialysis
- 6.2.2 Acute dialysis
- 6.3 Consumables
- 6.3.1 Dialyzers
- 6.3.2 Catheters
- 6.3.3 Access products
- 6.3.4 Concentrates
- 6.3.5 Other consumables
- 6.4 Equipment
- 6.4.1 Dialysis machines
- 6.4.2 Water treatment systems
- 6.4.3 Other equipment
Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)
- 7.1 Key trends
- 7.2 In-center dialysis
- 7.3 Home dialysis
Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)
- 8.1 Key trends
- 8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Poland
- 8.3.7 Sweden
- 8.3.8 Netherlands
- 8.3.9 Rest of Europe
- 8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Indonesia
- 8.4.7 Philippines
- 8.4.8 Malaysia
- 8.4.9 Rest of APAC
- 8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Chile
- 8.5.5 Colombia
- 8.5.6 Peru
- 8.5.7 Rest of LATAM
- 8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Israel
- 8.6.5 Turkey
- 8.6.6 Egypt
- 8.6.7 Rest of MEA
Chapter 9 Company Profiles
- 9.1 AngioDynamics, Inc.
- 9.2 Asahi Kasei Corporation
- 9.3 B. Braun Holding GmbH & Co. KG
- 9.4 Baxter International Inc.
- 9.5 Becton, Dickinson and Company
- 9.6 DaVita Inc.
- 9.7 Dialife SA
- 9.8 Fresenius SE and Co. KGaA
- 9.9 JMS Co Ltd
- 9.10 KAWASUMI LABORATORIES INC
- 9.11 Medtronic Plc.
- 9.12 Nikkiso Co. Ltd.
- 9.13 Nipro Medical Corporation
- 9.14 Rogosin Institute
- 9.15 Satellite Healthcare
- 9.16 Teleflex Incorporated
- 9.17 Toray Industries Inc.
- 9.18 U.S. Renal Care, Inc.
